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STUDY PROTOCOL
Digi-Do: a digital information tool to support 
patients with breast cancer before, during, 
and after start of radiotherapy treatment: 
an RCT study protocol
Sofi Fristedt1,2* , Frida Smith3,4, Annika Grynne5 and Maria Browall5,6
Abstract 
Background: Radiation Therapy (RT) is a common treatment after breast cancer surgery and a complex process 
using high energy X-rays to eradicate cancer cells, important in reducing the risk of local recurrence. The high-tech 
environment and unfamiliar nature of RT can affect the patient’s experience of the treatment. Misconceptions or 
lack of knowledge about RT processes can increase levels of anxiety and enhance feelings of being unprepared at 
the beginning of treatment. Moreover, the waiting time is often quite long. The primary aim of this study will be to 
evaluate whether a digital information tool with VR-technology and preparatory information can decrease distress as 
well as enhance the self-efficacy and health literacy of patients affected by breast cancer before, during, and after RT. 
A secondary aim will be to explore whether the digital information tool increase patient flow while maintaining or 
increasing the quality of care.
Method: The study is a prospective and longitudinal RCT study with an Action Research participatory design 
approach including mixed-methods data collection, i.e., standardised instruments, qualitative interviews (face-to-face 
and telephone) with a phenomenological hermeneutical approach, diaries, observations, and time measurements, 
and scheduled to take place from autumn 2020 to spring 2022. The intervention group (n = 80), will receive standard 
care and information (oral and written) and the digital information tool; and the control group (n = 80), will receive 
standard care and information (oral and written). Study recruitment and randomisation will be completed at two 
centres in the west of Sweden.
Discussion: Research in this area is scarce and, to our knowledge, only few previous studies examine VR as a tool 
for increasing preparedness for patients with breast cancer about to undergo RT that also includes follow-ups six 
months after completed treatment. The participatory approach and design will safeguard the possibilities to capture 
the patient perspective throughout the development process, and the RCT design supports high research quality. 
Digitalisation brings new possibilities to provide safe, person-centred information that also displays a realistic picture 
of RT treatment and its contexts. The planned study will generate generalisable knowledge of relevance in similar 
health care contexts.
Trial registration: ClinicalTrials.gov Identifier: NCT04394325. Registered May 19, 2020. Prospectively registered.
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Background
Among women, breast cancer is the most diagnosed 
cancer and the leading cause of cancer death world-
wide [1]. In 2019, the Swedish national cancer regis-
ter recorded 9225 cases of breast cancer; 9157 women 
and 68 men (0.7%). The incidence rate of breast can-
cer in Sweden is expected to continue to rise, due to 
an increase in both the general and ageing popula-
tion numbers [2]. Radiation Therapy (RT) is a com-
mon treatment (received by 75–80% of breast cancer 
patients) after surgery and is a complex process based 
on the use of high energy X-rays to eradicate cancer 
cells, important in reducing the risk of local recurrence 
[1]. While the RT procedure itself takes only a few min-
utes and is painless, it requires meticulous prepara-
tion and patients then need to attend the RT treatment 
centre 5 days a week for up to 3–5 weeks. Moreover, in 
Sweden, the waiting time is often quite long, sometimes 
up to 10  weeks [2]. The high-tech environment and 
unfamiliar nature of RT can affect the patient’s experi-
ence of the treatment [3–5]. Furthermore, misconcep-
tions or a lack of knowledge about RT processes can 
increase their levels of anxiety and enhance feelings of 
being unprepared at the beginning of treatment [6–8].
Having received correct information about future 
treatment may enable patients to realistically assess 
advantages and disadvantages as well as foresee possi-
ble treatment results. This may in turn create a feeling 
of increased knowledge and security as well as reduce 
distress for the patient [9–13]. A number of Swedish 
acts state that the healthcare system must provide each 
patient with individually tailored information and the 
opportunity to choose between different treatments 
[14–16] or stipulate that healthcare providers should 
actively ensure that the information has been received 
and understood by the patient [10]. Having a person-
centred approach to information provision and com-
munication means to enhance shared decision making, 
seeing the person as a capable individual who wants to 
adapt generic information to his or her social context 
and experiences [17, 18].
When informing patients, their health literacy must 
also be considered, i.e., their ability to acquire, under-
stand, and use information about their health, includ-
ing that related to cognitive and social functions [19]. 
Health literacy can be seen as being dynamic, and 
hence can fluctuate, depending on the state of the indi-
vidual, the situation, the culture, or the environment 
[20].
Self-efficacy, referring to a persons’ belief in his/her 
ability to deal with specific situations [21] such as in this 
case a cancer diagnosis, treatments, and transitioning to 
survivorship [22]. Cancer patients’ perceived self‐efficacy 
may directly or indirectly affect health behaviours, life-
style adjustments and psychological growth, psychologi-
cal distress, and physical outcomes, as well as quality of 
life (QoL) [23, 24]. Psychosocial distress may appear early 
in the diagnostic process and can have negative effects on 
compliance with treatment and subsequent quality of life 
[22].
There is a need for new ways to inform and involve 
patients, hence there is a strong call for digitalized tools 
to be used in healthcare. To be effective, however, digi-
tal tools must be developed based on research that also 
follows quality standards [25]. More and more, patients 
request they are provided information through videos, 
accessible for later review at home and for sharing with 
loved ones, as many patients travel substantial distances 
to receive care [26]. Furthermore, videos and audio-vis-
ual materials have proven to be successful communica-
tion tools and the format also supports the distribution 
and sharing of information with others [27–29]. Virtual 
reality (VR) has the inherent potential to be interactive 
because its content is generated in real time, not ahead of 
time, which makes the experience even more immersive 
[30]. Specifically, VR differs from other forms of media 
because it induces the sense of “presence”, i.e., the feeling 
of “being there” inside the virtual experience produced by 
the technology [31]. VR-interventions for cancer patients 
were investigated in a meta-analysis by Zeng et  al. [32], 
showing its effects on improved learning through cogni-
tive training and significantly decreased fatigue. A recent 
study indicated that a virtual reality education for breast 
cancer patients could improve RT knowledge and per-
haps decrease anxiety as well as was appreciated by the 
patients [12]. Moreover, virtual reality radiotherapy edu-
cational program could have a positive effect on patients 
prior to their initial RT session by providing them with 
useful content and decreasing their anxiety about the 
process, thus increasing the patient RT comprehension 
[33].
In another study, the majority (86%) of the partici-
pants considered that the information they received did 
not provide them with an adequate understanding of the 
treatment and what it entailed [34]. Participants identi-
fied potential benefits of VR video viewing before the first 
day of treatment and felt that it could increase under-
standing of the treatment process, specifically the spatial 
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and acoustic aspects of treatment. The authors concluded 
that a VR education tool has the potential to enhance 
standard patient education, increasing understanding of 
treatment and decreasing anxiety.
However, the potential outcomes related to Health 
Literacy are scarcely evaluated. Moreover, most stud-
ies were of relatively low methodological quality or pilot 
studies and the need for research of more robust study 
design and larger sample sizes has been identified.
The primary aim of this study will be to evaluate 
whether a digital information tool with VR-technology 
and preparatory information can decrease distress as well 
as enhance the self-efficacy and health literacy of patients 
affected by breast cancer before, during, and after RT. 
A secondary aim will be to explore whether the digital 
information tool increase patient flow while maintaining 
or increasing the quality of care.
Methods
Study design
The study (ClinicalTrials.gov Identifier: NCT04394325) is 
a prospective and longitudinal RCT study with an Action 
Research (AR) participatory design approach, including 
mixed-method data collection, i.e., standardised instru-
ments, interviews (face-to-face and telephone), diaries, 
observation, and time measurements. To ensure trans-
parency and rigour the CONSORT [35] checklist for 
randomised trials and COREQ [36] checklist for quali-
tive research will be applied. The timeline for the study 
is scheduled between autumn 2020 to spring 2022. The 
study will consist of two arms: (A) an intervention group 
(n = 80), who will receive standard care and information 
and the digital information tool; and (B) a control group 
(n = 80) who will receive standard care and information 
(oral and written). Recruitment and randomisation will 
be completed at two hospitals in the Western part of 
Sweden. Two nurses will act as research assistants at the 
respective hospitals.
Sample
Adult patients (> 18 years) diagnosed with breast cancer, 
stage I–II, who are not receiving adjuvant or neo-adju-
vant chemotherapy or anti-Her-2 treatment and with RT 
as additional treatment after surgery, will be consecu-
tively included during the planned post-operative visit to 
the surgical clinic. They will also need the ability to read, 
write, and understand Swedish to adhere to the digital 
information tool and the data collection instruments, 
and have access to a smartphone or a tablet. Patients 
responding to these inclusion criteria will be consecu-
tively asked to participate at the post-surgery follow-up 
visit and receive information (oral and written) about the 
study. After providing their signed informed consent, 
participants will be randomized to either the interven-
tion group (A) or the control group (B) by drawing a note 
(marked with group A or B) for each participant from a 
black box. Randomization will be stratified by hospital, 
and a total of 80 participants will be finally included at 
each hospital (40 in each group). The participants in the 
intervention group will receive oral and written informa-
tion regarding the digital information tool.
Sample size and hypothesis
The Distress Thermometer will be used as the primary 
outcome measure and used as a basis for the power 
calculation. A sample size of 63 persons in each group 
(a total of n = 126) would give an 85% power to detect 
a 0.10 improvement in the intervention group at an 
alpha = 0.05.
The null hypothesis is that there is no difference in 
distress between the intervention group and the control 
group; the alternative hypothesis is that the intervention 
group will experience 10% lower distress than the control 
group at the follow-up, six months post-completion of 
RT. The anticipated recruitment rate is 4.4 participants 
per site and month.
Development and testing of the digital information tool 
(Digi‑Do)
As a pre-phase, a pilot study was performed for the 
development and testing of the digital information tool 
(Digi-Do), approved by the Regional Ethics Committee 
(Dnr 917-17) with 30 patients in total (15 women with 
breast cancer and 15 men with prostate cancer). The 
Digi-Do tool was developed through a co-design process, 
where patients and staff were involved in all design steps; 
initial exploration of work, discovery process and pro-
totyping [37]. According to the study’s co-design, itera-
tive methodology [38 in manuscript], changes have since 
been made to the digital information tool and a second 
version has now been developed for the full RCT. The 
present study has been approved by the Swedish Ethical 
Review Authority (Dnr 2020-00170). An ongoing system-
atic literature review will also guide the present study, 
and the project is registered in PROSPERO (PROSPERO; 
168073).
The digital information tool applied in this project 
is divided into two separate but coherent applications 
(apps) for mobile devices: one (VR-app) with a guided 
tour of the RT-department with a voice-over to describe 
360 images to create a sense of actually having visited 
the department prior to start of RT, and one (informa-
tion app) containing information obtained through the 
pre-treatment phase. If a VR-effect is not desirable, the 
patient can complete the simulated study-visit on their 
mobile phone or tablet as well as present the images in 
Page 4 of 7Fristedt et al. BMC Med Inform Decis Mak           (2021) 21:76 
the browser of an integrated media player. Three areas 
of information are available in the information app: (1) 
Q&As from the existing written information, presented 
both in writing and a recorded voice; (2) practical infor-
mation, such as maps, public transportation options with 
relevant links to public transport, telephone numbers, 
and information about possibilities for staying at the 
patient hotel; and (3) three short animated films about 
cancer and physical activity during RT.
Data collection
Socio-demographic data concerning age, marital sta-
tus, number of persons in household, level of education, 
working/retired/sick leave, stage of disease, co-morbid-
ities, and treatment will be gathered from the patients 
and/or their medical charts. The instruments for data 
collection will be administrated in person or by post at 
the baseline collection, and by post (including a pre-paid 
return envelope) on consecutive collections (Table  1). 
Two reminders will be sent for each data collection, sepa-
rated two weeks in time if necessary. Data will be coded 
and manually entered in SPSS. The SPSS database will 
be stored on a secure digital storage (JU share files) at 
Jönköping University.
Primary outcome measure
DIS-A. The NCCN Distress Thermometer is a brief screen-
ing tool for cancer patients to assess psychosocial distress 
[39], including 34 dichotomous items on the presence of 
physical, emotional, family, practical, and spiritual prob-
lems. A score of 4.5 or higher indicates the patient is dis-
tressed and in need of support. The Swedish translation 
of the DT/PL is consistent with the original English ver-
sion [40].
Secondary outcome measure
The General Self-efficacy Scale [41], validated into Swed-
ish GSES [42] is an instrument that asks the persons´ 
opinion about how he or she can deal with difficulties and 
challenges in life. It consists of 10 items (eg. “I can always 
manage to solve difficult problems if I try hard enough”, “I 
am confident that I could deal efficiently with unexpected 
events” and “I can usually handle whatever comes my 
way”) rated on a four-point Likert scale (“not at all true” 
to “exactly true”), summarized across respondents (range 
10–40); higher scores indicate higher self-efficacy.
The communicative and critical health literacy scale—
Swedish version: This instrument consists of five items 
self-rated on a five-point Likert scale, ranging from “not 
at all” to “precisely”. The first three items include state-
ments focusing on the capacity for collecting, extract-
ing, and understanding relevant health information. The 
other two items include statements highlighting capaci-
ties to judge the reliability of the information and to apply 
health information to everyday life. In this study we have 
added an open-ended question concerning information 
sources [43, 44].
The Swedish Functional Health Literacy scale: This scale 
comprises five items about persons’ skills in reading and 
understanding health information. The items can be self-
assessed on a five-point Likert scale ranging from ‘never’ 
to ‘often’. In this study, we have excluded two of the origi-
nal questions (difficulty reading health information and 
time to read health information) as these were found 
to be less relevant in relation to our aim, and we added 
one open-ended question concerning how to remember 
information relating to health, illness, and treatment [44].
The eHealth Literacy Questionnaire (eHLQ) is a psy-
chometrically robust multidimensional tool designed to 
be used to understand and evaluate people’s interaction 
with digital health services [45]. The eHLQ consists of 7 
scales capturing various attributes of the users and the 
intersection between users and technologies. The applied 
Swedish version of the eHLQ (translated from English) is 
currently undergoing validation testing (the results will 
be published during 2020).
The Self-Administered Comorbidity Questionnaire: The 
Swedish version of this scale has been modified from the 
Table 1 Data collections at different points in time
Point in time Data collections
Baseline Socio-demographic and co-morbidity data
Distress (DIS-A); Self-efficacy (GSES); Health literacy 
(functional, communicative & critical, e-HLQ)
Notebook written by 30 patients
Week of commencing RT treatment Distress (DIS-A)
Notebook collected and returned after reading
Within a month of completion of RT treatment In depth/or telephone interviews with participants
Six months post-completion of RT treatment Distress (DIS-A); Self-efficacy (GSES); Health literacy 
(functional, communicative & critical, e-HLQ)
Telephone interviews with participants
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English version, and is a method to assess comorbidity 
for clinical and health services research [46].
Time measurements and field notes
Ten patients respectively from groups A and B will, dur-
ing the planned post-operative visit to the surgical clinic, 
be consequently asked to participate in the time meas-
urement and observational part of the study (n = 20). 
Three of the planned treatments for the first week of RT, 
and, additionally, one session in the last week of treat-
ment, will be measured based on seven timepoints; 
patient enters door of RT room, patient lies on table, 
first image, first field beam on, last field beam on, patient 
leaves table, and patient leaves RT room. During each 
RT session, questions asked by patients and staff will be 
documented as field notes, including what subjects are 
addressed, who initiates the question, and whether, how, 
and to where the staff refers the patient for further infor-
mation. These field notes will be taken into account for 
validation of the content of the information in the app, 
but not further analysed.
Notebook and in‑depth interviews
Approximately 30 patients (in group A) will be strategi-
cally asked to participate in the qualitative part of the 
study. The patients will be asked to make notes in a note-
book during the waiting period prior to the start of RT 
as well as during the RT treatment period. The partici-
pants will be encouraged to write reflections with a focus 
on the support, guidance, and information they receive 
from healthcare professionals, relatives, and the digital 
information tool in these notebooks. In the first week 
of RT treatment, patients will submit their diaries to the 
researchers. The text in the notebooks will be read and 
summarized to support the development of in-depth 
questions for upcoming individual interviews. These 
individual in-depth and/or telephone interviews will take 
place on two occasions (1–4  weeks and 6  months post-
RT completion) and with at least ten of the patients who 
have accepted participation and have made regular notes. 
Questions will include topics such as their experiences 
of receiving the information through the digital informa-
tion tool during the waiting time and treatment period, 
of using the digital information tool, to what extent the 
digital information has affected their involvement and 
preparedness for the radiation treatment, as well as their 
experiences during the time since the end of RT.
Data analysis
Quantitative data
Data will be analysed descriptively taking the level of 
scale into consideration, i.e., using mean (m) and stand-
ard deviation (SD) when relevant, or, otherwise, median 
(md) and range. Group comparison at each point in time 
will be completed using relevant parametric or non-par-
ametric methods [47]. P values < 0.05 will be considered 
statistically significant. Generalized linear models [47] 
will be used to analyse differences between groups and 
for repeated measures over time for the continuous vari-
ables, while nominal (categorical) variables will be tested 
with chi-square test (exact).
Qualitative data
A phenomenological hermeneutical approach, with a 
focus on the essence and the underlying meaning in the 
lived experience of receiving RT, will be applied [48]. 
Narratives, in the form of notebook texts, recorded by the 
participants, and in-depth interviews that encompasses 
descriptions and expressions of the person´s lived experi-
ences of the phenomenon will be analysed. The analysis 
involves three steps [48, 49]: (1) the naïve reading, where 
the text is read numerous times and the researchers ini-
tial understanding of the text is written down. (2) The 
structural analyses, where the text is broken down into 
meaning units, that embody information about the phe-
nomenon of interest. (3) The comprehensive understand-
ing, in which the text is considered in its entirety, and 
the findings from the first and second steps, are brought 
together with the researchers pre-understanding, and 
discussed in relation to relevant literature.
Discussion
Research in this area is scarce and, few other studies have 
examined VR as a tool for increasing preparedness for 
patients with breast cancer about to undergo RT that also 
includes follow-ups up to six months after completed 
treatment. Previous studies on VR for the same purpose 
are small e.g. [12], while yet including a control and inter-
vention group. Other studies such as [9] that intends to 
improve patient education for patient with RT, are not 
based on VR tools.
The participatory approach and design will safe-
guard the possibilities to capture the patient perspec-
tive throughout the development process, and the RCT 
design supports high research quality. Because the pro-
ject utilises rather novel technology, it is clearly impor-
tant to include patient perspectives to ensure that 
persons with less digital competence are not deprived 
of or alienated from the information. Patients diagnosed 
with breast cancer of different ages will be included. 
This will likely provide us with a sample representing 
persons of different experiences and variations in life 
situations and self-efficacy, as well as in their digital com-
petence and health literacy. Such diversity is important 
to generate as broad a knowledge base as possible for the 
design of future research projects with different cancer 
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diagnoses and clinical decision-making in relation to RT. 
The outcomes of this project will be put to practical use, 
both during and after the research period. The project 
will contribute to clinical cancer research and innova-
tion by leading to better informed and better prepared 
patients. Using the waiting time actively as a part of the 
process of preparing can make this period more mean-
ingful for the patient.
The digital information tools utilised in the present 
project are also likely to add value to patients’ next-of-
kin, by providing a more concrete picture of the treat-
ment and its context. This brings unique possibilities for 
an unlimited number of next-of-kin of all ages to better 
understand what their mother, sister, daughter, friend, 
etc. is experiencing. This will in turn increase the psy-
chosocial support provided to patients and loved ones, 
thus strengthening the patients’ position in cancer care. 
The VR innovation creates opportunities for improving 
care processes and levelling uneven structures. The pro-
ject may also improve the efficiency of RT by leading to 
well-prepared patients. The mobile applications can be 
regarded as an accessible and convenient platform that 
enables the person to gain instant knowledge and guid-
ance [50].
Because the participatory design builds on collabora-
tion with patients, as well as staff, it will also generate 
knowledge and a digital information tool that will be 
easy to implement in clinical practice in similar settings. 
Moreover, participatory designs support the three Rs of 
research; namely, to enhance rigor, assure relevance, and 
ensure a greater as well as broader reach [51].
Conclusion
. This study will tell us whether a digital information 
tool with VR-technology and preparatory information 
can decrease distress as well as enhance self-efficacy and 
health literacy of patients with a breast cancer about to 
receive RT. It will also indicate whether a digital infor-
mation tool can increase patient flow while maintaining 
or increasing the quality of care. The planned study will 
generate generalisable knowledge of relevance in similar 
health care settings and for patients with other diagnosis 
of cancer about to receive RT.
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